# ResVita Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/resvita-bio

- Industry: Biotechnology
- Headquarters: Berkeley, US
- Website: www.resvitabio.com
- Latest round: Seed (Dec 6, 2023)
- Investors on record: 1

## About

Based in California, US, and founded in 2021, ResVita Bio operates as a biotechnology company that develops skin microbial platform by using synthetic biology and metabolic engineering. In December 2023, ResVita Bio raised seed funding from the Pioneer Fund. As of January 2024, the company is led by its CEO Amin Zargar.

ResVita Bio's flagship product is a skin microbial platform that offers a solution to target underlying protein imbalances associated with aging and various skin diseases like Netherton Syndrome, atopic dermatitis, psoriasis, acne, and rosacea. The company involves the application of proprietary cells that undergo dermatological testing, ensuring they are non-irritating and non-allergenic, as well as producing missing proteins directly in the skin.

## Funding rounds

- Seed, Dec 6, 2023 — Pioneer Fund

## Investors

- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed